معرفی
Professor John Simes AO is a Professor of Clinical Epidemiology at the University of Sydney's Faculty of Medicine and holds leadership roles at the NHMRC Clinical Trials Centre (CTC), including Senior Associate Director and Co-Director of Cancer Trials. He has led over 100 multicenter clinical trials, notably the LIPID and FIELD trials, contributing to global guidelines in cardiovascular and diabetes care. His research spans cancer, cardiovascular disease, neonatal medicine, and clinical trial methodology.
Education: BSc (Med), MBBS, FRACP, SM (Harvard), MD. He is a practicing Medical Oncologist at Royal Prince Alfred Hospital and Chris O'Brien Lifehouse.
Research Interests: Large-scale clinical trials in oncology (e.g., gastrointestinal, genitourinary cancers), cardiovascular risk reduction, and neonatal medicine. Notable contributions include demonstrating pravastatin's survival benefits (LIPID trial) and fenofibrate's microvascular benefits (FIELD trial). Current trials include INTEGRATE (gastric cancer) and INSPIRE (aspirin in VTE).
Awards: Order of Australia (2020), MOGA Cancer Achievement Award (2010), Harvard Biostatistics Alum Award (2009), and R.T. Hall Prize (1999).
- Advising: Supervises students like Janene Dalrymple on translational research.
- Grants: Holder of NHMRC Senior Principal Research Fellowship and Program Grants.
- Labs/Teams: Leads CTC's oncology trials group and chairs INSPIRE Steering Committee.
